In one paragraphArticle in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
17 authors.
Medina GurzhikhanovaDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology, 117198 Moscow, Russia.ORCID 0000-0002-0411-9485 Sergei FomenkoBiotech Campus LLC, 117437 Moscow, Russia.
Olga MusharovaBiotech Campus LLC, 117437 Moscow, Russia.
Tatyana SalimovaDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology, 117198 Moscow, Russia.
Olga GoronkovaDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology, 117198 Moscow, Russia.
Ruslan AbasovDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology, 117198 Moscow, Russia.ORCID 0000-0001-9179-8430 Elena RaykinaDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology, 117198 Moscow, Russia.
Fizaliia KhisamievaThe State Autonomous Healthcare Institution "Children's Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan", 420064 Kazan, Russia.
Evgeny ImyanitovDepartment of Tumor Growth Biology, N.N. Petrov Institute of Oncology, 197758 Saint Petersburg, Russia.ORCID 0000-0003-4529-7891 Anna SokolenkoDepartment of Tumor Growth Biology, N.N. Petrov Institute of Oncology, 197758 Saint Petersburg, Russia.ORCID 0000-0001-6304-1609 Alexey MaschanDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology, 117198 Moscow, Russia.
Michael MaschanDmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology, 117198 Moscow, Russia.ORCID 0000-0003-1735-0093 Funding
Russian Science Foundation 21-75-30015
6 · The paper itselfAbstract
Thiamine-responsive megaloblastic anemia (TRMA) is a rare autosomal recessive disorder caused by biallelic loss of function variants in the
Indexed as
Anemia, MegaloblasticDiabetes MellitusDiabetes Mellitus, Type 1Founder EffectHearing Loss, SensorineuralKetoglutarate Dehydrogenase ComplexMembrane Transport ProteinsMutationThiamine DeficiencyChild, PreschoolFemaleHomozygoteHumansInfantMaleThiamineKetoglutarate Dehydrogenase ComplexMembrane Transport ProteinsSLC19A2 protein, humanThiaminefounder effectRogers syndromeSLC19A2thiamine-responsive megaloblastic anemiawhole-genome sequencing
Identifiers
PMID42511616
PMCPMC13409991
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390